Isracann Biosciences Inc.
ISCNF
$0.00
$0.000.00%
OTC PK
| 08/31/2022 | 05/31/2022 | 02/28/2022 | 11/30/2021 | 08/31/2021 | |
|---|---|---|---|---|---|
| Net Income | 34.88% | 87.84% | 62.59% | 31.78% | -101.93% |
| Total Depreciation and Amortization | -3.57% | -15.46% | 7.89% | 12.16% | 15.07% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 134.20% | -89.68% | -93.41% | -68.65% | 88.71% |
| Change in Net Operating Assets | 130.48% | 494.87% | -65.49% | 1,429.66% | 120.41% |
| Cash from Operations | 64.35% | 80.94% | 45.34% | 52.94% | 46.41% |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | 100.00% | -- | -- | -- |
| Cash from Investing | -- | 135.31% | -- | -100.00% | -- |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -- | -84.76% | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -- | -85.14% | -- | -- | -- |
| Foreign Exchange rate Adjustments | -1,450.00% | -3,900.00% | 833.33% | 2,400.00% | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 97.26% | 73.69% | -275.61% | 53.05% | -2.04% |